Prediction of thyroid cancer based on a multifactorial logistic model and the distribution of the linear predictor

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Altai region has high incidence of thyroid cancer (TC) which served as motivation for development of a multivariable logistic prognostic model based on clinical and amnestic patient data with determination of low, intermediate, and high risks of the disease. The use of the model in clinical practice can promote optimization of examination volume and formation of priority groups for in-depth diagnostics.

Aim. To evaluate diagnostic value of a multivariable logistic model for TC prognosis and analyze distribution of a linear predictor in various clinical groups for identification of areas of low, intermediate and high risks.

Materials and methods. Single-center retrospective study including 1463 patients with diseases of the thyroid was conducted. The main group consisted of 505 sequentially examined and surgically treated patients with morphologically confirmed TC; the control group included 958 patients without oncological pathology of the thyroid (operated due to suspicion of a tumor with subsequent morphological exclusion and selected during prophylactic examinations). The set of clinical-anamnestic, anthropometric, and phenotypic characteristics was formed based on the results of previously published study on TC risk factors in the Altai population. Using survey patient data, a set of characteristics Х1–X26 was composed. Statistical analysis included descriptive statistics, univariate logistic analysis with categorization of quantitative variables per ROC criteria, as well as development of a multivariate logistic model with stepwise predictor selection. For the final model, χ2 test, area under the ROC curve (AUC), sensitivity and specificity at optimal threshold were assessed; internal validation was performed using the bootsrap method. For clinical interpretation, distribution of a linear predictor z was analyzed in the TC group, non-TC group, as well as in patients with diffuse and nodular diseases of the thyroid and subgroups with stage T1a–4 tumors.

Results. The final multivariate logistic model included a limited set of independent demographic, anthropometric, and anamnestic predictors and demonstrated satisfactory discriminating ability with acceptable AUC values per internal validation. Distribution of the linear predictor showed increase in z values in patients with TC. Small range of values of this parameter was predominantly observed in patients without TC, presence of marked "grey area" – in patients with diffuse and nodular thyroid diseases. Comparison of T categories did not show clear correlation between T stage and the value of the linear predictor.

Conclusion. The multivariate logistic model developed based in clinical and anamnestic data of the Altai patients allows to identify 3 areas of linear predictor z values corresponding to low, intermediate, and high TC risks. Its application in clinical practice can promote rationalization of examination volume and identification of priority groups for in-depth diagnostics in regions with high TC morbidity.

About the authors

I. M. Zakharova

Altai Regional Oncology Dispensary, Ministry of Health of Russia; Altai State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: zaxarova270494@mail.ru
ORCID iD: 0000-0003-2225-619X
Russian Federation, 77 Nikitina St., Barnaul, 656045; 40 Lenina Prospekt, Barnaul, 656038

A. F. Lazarev

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0000-0003-1080-5294
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

I. V. Vixlyanov

Altai Regional Oncology Dispensary, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0000-0003-3290-7187
Russian Federation, 77 Nikitina St., Barnaul, 656045

N. V. Trukhacheva

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0000-0002-7894-4779
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

N. D. Tixonskii

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0001-3077-1776
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

E. K. Semeryanova

Altai Regional Oncology Dispensary, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0009-9234-7020
Russian Federation, 77 Nikitina St., Barnaul, 656045

R. E. Yudin

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0008-0662-163X
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

A. V. Arefeva

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0006-3875-0407
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

L. E. Kargapolov

Altai Regional Oncology Dispensary, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0007-7398-9162
Russian Federation, 77 Nikitina St., Barnaul, 656045

D. A. Sheludkov

Altai Regional Oncology Dispensary, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0001-8851-967X
Russian Federation, 77 Nikitina St., Barnaul, 656045

M. M. Peretyatko

Altai State Medical University, Ministry of Health of Russia

Email: zaxarova270494@mail.ru
ORCID iD: 0009-0004-6362-9823
Russian Federation, 40 Lenina Prospekt, Barnaul, 656038

References

  1. Sung H., Ferlay J., Siegel R.L., Laversanne M. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74(3):229–63. doi: 10.3322/caac.21834
  2. Shank J.B., Are C., Wenos C.D. Thyroid cancer: global burden and trends. Ind J Surg Oncol 2022;13(1):40–5. doi: 10.1007/s13193-021-01429-y
  3. Dou Z., Shi Y., Jia J. Global burden of disease study analysis of thyroid cancer burden across 204 countries and territories from 1990 to 2019. Front Oncol 2024;14:1412243. doi: 10.3389/fonc.2024.1412243
  4. Hoang J.K., Nguyen X.V., Davies L. Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol 2015;22(8):1024–9. doi: 10.1016/j.acra.2015.01.019
  5. Davies L., Hoang J.K. Thyroid cancer in the USA: current trends and outstanding questions. Lancet Diabetes Endocrinol 2021;9(1):11–2. doi: 10.1016/S2213-8587(20)30372-7
  6. Dal Maso L., Vaccarella S., Franceschi S. Trends in thyroid cancer incidence and overdiagnosis in the USA. Lancet Diabetes Endocrinol 2025;13(3):167–9. doi: 10.1016/S2213-8587(24)00343-7
  7. Kitahara C.M. The growing global burden of thyroid cancer over diagnosis. Lancet Diabetes Endocrinol 2024;12(11):780–2. doi: 10.1016/S2213-8587(24)00269-9
  8. Baloch Z.W., Asa S.L., Barletta J.A. et al. Update from the 2022 World Health Organization classification of thyroid neoplasms. Endocr Pathol 2022;33(1):27–63. doi: 10.1007/s12022-022-09707-3
  9. Захарова И.М., Лазарев А.Ф., Петрова В.Д. Анализ динамики заболеваемости раком щитовидной железы в Алтайском крае с акцентом на вклад папиллярных микрокарцином в структуру заболевания. Российский онкологический журнал 2025;30(1):31–40. doi: 10.17816/onco643155 Zakharova I.M., Lazarev A.F., Petrova V.D. Analysis of the dynamics of thyroid cancer incidence in the Altai Territory with an emphasis on the contribution of papillary microcarcinomas to the structure of the disease. Rossijskiy onkologicheskiy zhurnal = Russian Journal of Oncology 2025;30(1):31–40. (In Russ.). doi: 10.17816/onco643155
  10. Захарова И.М., Лазарев А.Ф., Петрова В.Д. Возможные факторы риска развития рака щитовидной железы на примере жителей Алтайского края. Исследования и практика в медицине 2025;12(1):86–98. doi: 10.17709/2410-1893-2025-12-1-6 Zakharova I.M., Lazarev A.F., Petrova V.D. Possible risk factors for thyroid cancer on the example of residents of the Altai Territory. Issledovaniya i praktika v meditsine = Research and Practice in Medicine 2025;12(1):86–98. (In Russ.). doi: 10.17709/2410-1893-2025-12-1-6
  11. Hosseini Sarkhosh S.M., Shirzad N., Taghvaei M. et al. Prediction of thyroid malignancy risk using clinical and ultrasonography features and a machine learning approach. Eur Radiol 2025;35(9):5157–67. doi: 10.1007/s00330-025-11434-2
  12. Cao Y., Yang Y., Chen Y. et al. Optimizing thyroid AUS nodules malignancy prediction: a comprehensive study of logistic regression and machine learning models. Front Endocrinol (Lausanne) 2024;15:1366687. doi: 10.3389/fendo.2024.1366687
  13. Liu Y., Zhang X., Wang H., Li J. et al. Establishment and validation of a multivariate logistic regression model for predicting malignancy in patients with thyroid nodules. Front Endocrinol 2024;15:1346284. doi: 10.3389/fendo.2024.1346284
  14. Zhang X., Ze Y., Sang J. et al. Risk factors and diagnostic prediction models for papillary thyroid carcinoma. Front Endocrinol (Lausanne) 2022;13:938008. doi: 10.3389/fendo.2022.938008

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2026 ABV-Press

License URL: https://ogsh.abvpress.ru/jour/about/editorialPolicies

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36990 от  21.07.2009.